Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bayshore Pharmaceuticals
Short Hills, New Jersey, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Bayshore Pharmaceuticals markets and distributes more than 14 FDA-approved generic drugs in the US, including recent launches of metolazone, etodolac, and ketotifen fumarate, serving indications in cardiovascular, pain/inflammation, and allergy. The company also distributes ANDA products for partner manufacturers
- Therapeutic areas
- ImmunologyNephrologyRheumatologyEndocrinologyGastroenterologyCardiovascularNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Beximco Pharmaceuticals (distribution)Pinellas Pharmaceuticals (collaboration on distribution and registration)
Beyond the preview
Go deeper on Bayshore Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bayshore Pharmaceuticals.